Moreover, the IMPACT study demonstrated that germline BRCA1/2 mutations can be used to identify men with higher risk of developing PCa, and are associated with a more aggressive phenotype and poorer outcome [4, 5]. Here, BRCA1 is linked to posterior cortical atrophy.